Jefferies Starts Kite Pharma (KITE) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- S&P 500, Dow futures dip as big banks' earnings roll in ahead of CPI data; IBM slides
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- SK Hynix’s record plunge drags down global chip stocks
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- IBM misses Q2 targets as mainframe and software sales disappoint
- Goldman Sachs Upgrades NIO (NIO) to Buy
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- YPF Energía Eléctrica S.A. files for proposed NYSE IPO
Credit Suisse Starts Kite Pharma (KITE) at Outperform
July 15, 2014 7:46 AM EDTCredit Suisse initiated coverage on Kite Pharma (NASDAQ: KITE) with an Outperform rating and a price target of $34.00.
Analyst Jason Kantor expressed enthusiasm for the CAR T and immuno-oncology space and the company's unique position in the field and fast-to-market strategy. Lead therapy,... More
Cowen Starts Kite Pharma (KITE) at Outperform
July 15, 2014 7:45 AM EDTCowen initiated coverage on Kite Pharma (NASDAQ: KITE) with an Outperform rating.
For an analyst ratings summary and ratings history on Kite Pharma click here. For more ratings news on Kite Pharma click here.
Shares of Kite Pharma closed at $24.05 yesterday.
... MoreStifel Nicolaus Starts Kite Pharma (KITE) at Buy
July 15, 2014 7:44 AM EDTStifel Nicolaus initiated coverage on Kite Pharma (NASDAQ: KITE) with a Buy rating and a price target of $31.00.
For an analyst ratings summary and ratings history on Kite Pharma click here. For more ratings news on Kite Pharma click here.
Shares of Kite Pharma closed at $24.05 yesterday.
... More